natgillin/translations-raw huggingface dataset:
Pen label Dose counter Dose pointer
pokrovček peresnika zunanji pokrovček igle notranji pokrovček igle igla papirna nalepka merilo preostanka insulina insulinsko okence nalepka injekcijskega peresnika števec odmerka kazalnik odmerka izbirnik odmerka potisni gumb
Important information about some of the ingredients of Tresiba This medicine contains less than 1 mmol sodium (23 mg) per dose.
Natrij To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni ‘brez natrija'.
Needle
Huda
Nocturnal confirmed hypoglycaemia was defined as episodes between midnight and 6 a.m. 5 The difference is for Tresiba Flex - Tresiba
5 To je razlika med Tresiba Flex - Tresiba.
Results support the use of Tresiba in adolescent patients with type 2 diabetes mellitus.
Uporaba zdravila Tresiba v kombinaciji z agonisti receptorjev GLP-1 pri bolnikih s sladkorno boleznijo tipa 2
The Poster for pharmacies/diabetic units shall contain the following key elements: - That Tresiba is available in 2 strengths; - Key differences in the design of the packages and the pre-filled pen devices; - When prescribing to make sure that the correct strength is mentioned in the prescription slip; - Always check the insulin label before dispensing to make sure the correct strength is delivered to the patient; - Always check the insulin label before each injection to avoid accidental mix-ups between the two different strengths of Tresiba; - Do not use outside of the pre-filled pen device (e.g. syringes); - Reporting of medication errors or any side effects.
V primeru poslabšanja vida se posvetujte z zdravnikom; • uporabo pravega insulina; pred injiciranjem vedno preverite nalepko insulina, da po pomoti ne zamenjate dveh različnih jakosti zdravila Tresiba, kot tudi drugih insulinskih zdravil.
NAME OF THE MEDICINAL PRODUCT Tresiba 100 units/mL solution for injection in cartridge insulin degludec
Navodilo za uporabo Tresiba 100 enot/ml raztopina za injiciranje v injekcijskem vložku insulin degludek
Tresiba 100 units/mL solution for injection in pre-filled pen insulin degludec
Tresiba 100 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin degludek
Initiation
Nosečnost
Based on your blood sugar level, your doctor may change your dose.
Zdravnik vam odmerek lahko spremeni glede na koncentracijo krvnega sladkorja.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING MULTIPACK LABEL (100 units/mL pre-filled pen (FlexTouch))
NALEPKA SKUPNEGA PAKIRANJA (Napolnjen injekcijski peresnik 100 enot/ml (FlexTouch))
PARTICULARS TO APPEAR ON THE INNER PACKAGING CARTON FOR MULTIPACK (200 units/mL pre-filled pen (FlexTouch))
PODATKI, KI MORAJO BITI NAVEDENI NA STIČNIH OVOJNINAH ŠKATLA SKUPNEGA PAKIRANJA (Napolnjen injekcijski peresnik 200 enot/ml (FlexTouch))
PARTICULARS TO APPEAR ON THE INNER PACKAGING CARTON FOR MULTIPACK (100 units/mL pre-filled pen (FlexTouch))
PODATKI, KI MORAJO BITI NAVEDENI NA STIČNIH OVOJNINAH ŠKATLA SKUPNEGA PAKIRANJA (Napolnjen injekcijski peresnik 100 enot/ml (FlexTouch))
PARTICULARS TO APPEAR ON THE OUTER PACKAGING MULTIPACK LABEL (200 units/mL pre-filled pen (FlexTouch))
NALEPKA SKUPNEGA PAKIRANJA (Napolnjen injekcijski peresnik 200 enot/ml (FlexTouch))
NAME OF THE MEDICINAL PRODUCT Tresiba 100 units/mL solution for injection in pre-filled pen insulin degludec
Navodilo za uporabo Tresiba 100 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku insulin degludek
Start by checking your pen to make sure that it contains Tresiba 200 units/mL, then look at the illustrations below to get to know the different parts of your pen and needle.
Začnite tako, da preverite injekcijski peresnik in se tako prepričate, da vsebuje zdravilo Tresiba 200 enot/ml.
• If severe low blood sugar is not treated over time, it can cause brain damage.
• Nezdravljeno hudo znižanje krvnega sladkorja lahko povzroči (prehodno ali trajno) okvaro možganov ali celo smrt.
Tresiba 200 units/mL solution for injection in pre-filled pen
Tresiba 100 enot/ml raztopina za injiciranje v injekcijskem vložku
NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Tresiba 200 units/mL solution for injection insulin degludec
Tresiba 200 enot/ml raztopina za injiciranje insulin degludek
Pack sizes of 1 (with or without needles), 5 (without needles) and multipack of 10 (2 x 5) (without needles) pre-filled pens of 3 mL.
Pakiranja z 1 (z iglami ali brez), s 5 (brez igel) in skupno pakiranje z 10 (2 x 5, brez igel) napolnjenimi injekcijskimi peresniki po 3 ml. Na trgu morda ni vseh navedenih pakiranj.
• thyroid hormones, for thyroid problems
• ščitnične hormone (uporabljajo se za zdravljenje motenj v delovanju žleze ščitnice),
INFORMATION IN BRAILLE Tresiba cartridge 100
Tresiba vložek 100
This may lead to too high blood sugar level.
Je lahko zelo nevarna, saj se lahko v primeru zelo nizkega krvnega sladkorja onesvestite.
Close glucose monitoring is recommended during the transfer and in the following weeks.
Ob prehodu ter nekaj tednov po njem je priporočljivo skrbno spremljanje koncentracije glukoze v krvi.
(sinusitis), o inflamed nose or throat (nasopharyngitis) (signs of this may include a cold or a sore throat).
Pogosti - okužba spolovil (gobice) na spolnem udu ali v nožnici (med znaki so lahko draženje, srbenje,
< 8.0% ≥ 8% to < 9.0% ≥ 9.0%
< 8,0 % ≥ 8 % do < 9,0 % ≥ 9,0 %
The recommended dose is two tablets once a day.
Priporočeni odmerek sta dve tableti enkrat na dan.
Your blood sugar may rise without this medicine.
Krvni sladkor se vam lahko brez tega zdravila zviša.
Possible signs of dehydration are listed in section 4.
Možni znaki dehidracije so navedeni v poglavju 4.
(when used with SU)
(v primeru uporabe s SU)
Take the tablets at around the same time each day.
- Tablete jemljite približno vsak dan ob istem času.
The requirements for submission of PSURs for this medicinal product are set out in the list of Union references dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
Zahteve glede predložitve PSUR za to zdravilo so določene v seznamu referenčnih datumov EU (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES, in vseh kasnejših posodobitvah, objavljenih na evropskem spletnem portalu o zdravilih.
Take your tablets with food.
- Tablete vzemite s hrano.
Do not store above 30°C.
Shranjujte pri temperaturi do 30 °C
In both cases, treatment with Qtrilmet may be restarted once the patient's condition has stabilised.
V obeh primerih se sme zdravljenje z zdravilom Qtrilmet znova začeti, ko se bolnikovo stanje stabilizira.
Fournier's gangrene has to be treated immediately.
Fournierjeva gangrena zahteva takojšnje zdravljenje.
If pregnancy is detected, treatment with this medicinal product should be discontinued.
Če je ugotovljena nosečnost, je treba zdravljenje s tem zdravilom prenehati.
This is to reduce the risk of side effects on the stomach.
Tako boste zmanjšali tveganje za neželene učinke na želodec.
Randomised and treated patients.
Randomizirani in zdravljeni bolniki.
A GFR should be assessed before initiation of treatment with metformin containing medicinal products and at least annually thereafter.
GFR je treba oceniti pred začetkom zdravljenja z zdravili, ki vsebujejo metformin, potem pa vsaj enkrat na leto.
This is normal and what is left of the tablet after all the medicine has been released.
To je normalno; ovojnica je tisto, kar ostane od tablete, ko se vse zdravilo sprosti.
Lactic acidosis is a medical emergency and must be treated in a hospital.
Laktacidoza je nujno stanje, ki ga je treba zdraviti v bolnišnici.
The efficacy and safety profiles of Qtrilmet in these patients have not been established.
Profila učinkovitosti in varnosti zdravila Qtrilmet pri teh bolnikih nista ugotovljena.
Consideration of such etiology is recommended if a patient presents with megaloblastic anaemia.
Možnost takšne etiologije je treba upoštevati, če se bolniku pojavi megaloblastna anemija.
No benefit was observed for MACE or all-cause mortality.
Opažali niso nobene koristi niti glede MACE niti glede umrljivosti zaradi vseh vzrokov.
Like for all diabetic patients it is important to counsel patients on routine preventative foot care.
Kot pri vseh bolnikih s sladkorno boleznijo je pomembno bolnikom svetovati glede redne preventivne nege stopal.
Your kidney function will be checked at least once every year or more frequently if you are elderly or if you have worsening kidney function.
Delovanje ledvic vam bodo preverjali vsaj enkrat na leto, lahko pa še pogosteje, če ste starejša oseba ali se vam delovanje ledvic slabša.
To avoid overdose, do not continue taking the separate tablets of these medicines as well as Qtrilmet.
Da bi preprečili preveliko odmerjanje, ne nadaljujte jemanja ločenih tablet teh zdravil hkrati z zdravilom Qtrilmet.
This leads to a high level of sugar (glucose) in your blood.
To povzroči visoko koncentracijo sladkorja (glukoze) v krvi.
Periodic safety update reports (PSURs)
• Redno posodobljena poročila o varnosti zdravila (PSUR)
The numerical imbalance of breast, bladder, and prostate tumours must be considered with caution; it will be further investigated in post-authorisation studies.
Številsko neravnovesje pri tumorjih dojke, sečnega mehurja in prostate je treba tolmačiti previdno; to bo dodatno raziskano v študijah po izdaji dovoljenja za promet z zdravilom.
Occasionally, the inactive ingredients of this medicine will be eliminated in the faeces as a soft, hydrated mass that may resemble the original tablet.
Včasih se lahko neaktivne sestavine tega zdravila izločijo v blatu kot mehka, hidrirana masa, ki je lahko podobna originalni tableti.
Swallow the tablets whole with half a glass of water.
Jemanje tega zdravila - Tablete zaužijte cele s pol kozarca vode.
o film-coating:
o Filmska obloga:
Generally, the most common adverse events reported in ≥ 65 years old were similar to < 65 years old.
Na splošno so bili najpogostejši neželeni učinki, ki so bili zabeleženi pri osebah, starih ≥ 65 let, podobni kot pri osebah, starih < 65 let.
Saxagliptin: Elderly patients (65-80 years) had about 60% higher saxagliptin AUC than young patients (18-40 years).
Saksagliptin: Starejši bolniki (65-80 let) so imeli vrednost AUC saksagliptina približno 60 % večjo kot mladi bolniki (18-40 let).
The mean Vd ranged between 63-276 L.
Povprečni Vd je od 63 do 276 l.
The remaining 219 patients started to take 5 mg saxagliptin 16 weeks ahead of the study start.
Preostalih 219 bolnikov je začelo jemati 5 mg saksagliptina 16 tednov pred začetkom študije.
The dose should be taken as two tablets orally, once daily at the same time of the day, with food.
Odmerek morajo vzeti kot dve tableti, peroralno, enkrat na dan in vedno ob istem dnevnem času, skupaj s hrano.
A limited amount of data from the use of metformin in pregnant women does not indicate an increased risk of congenital malformations.
Maloštevilni podatki o uporabi metformina pri nosečnicah ne kažejo večjega tveganja za prirojene malformacije.
Proportion of patients achieving HbA1c < 7%
Delež bolnikov, ki so dosegli HbA1c < 7 %
Talk to your doctor about the best way to control your blood sugar while you are pregnant.
Posvetujte se z zdravnikom o tem, kako najbolje uravnavati krvni sladkor med nosečnostjo.
Frequency categories were defined according to very common (≥ 1/10), common (≥ 1/100 to ˂ 1/10), uncommon (≥ 1/1,000 to ˂ 1/100), rare ( 1/10,000 to < 1/1,000), very rare ( 1/100,000 to < 1/10,000) and not known (cannot be estimated from the available data).
Kategorije pogostnosti so bile opredeljene kot: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki ( 1/10.000 do < 1/1.000), zelo redki ( 1/10.000 do < 1/10.000), neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
What Qtrilmet is and what it is used for
Kaj je zdravilo Qtrilmet in za kaj ga uporabljamo
Your doctor may prescribe other medicines to lower the amount of sugar in your blood.
Zdravnik vam lahko predpiše še druga zdravila za znižanje sladkorja v krvi.
The majority of patients in this study had a baseline HbA1c of > 8% (see Table 4).
Večina bolnikov v tej študiji je imela izhodiščni HbA1c > 8 % (glejte preglednico 4).
Difference in HbA1c effect
Razlika v učinku na HbA1c
Use in patients at risk for volume depletion, hypotension, and/or electrolyte imbalances
Uporaba pri bolnikih s tveganjem za zmanjšanje volumna, hipotenzijo in/ali neravnovesje elektrolitov
In patients at increased risk of further progression of renal impairment and in the elderly, renal function should be assessed more frequently, e.g. every 3-6 months.
Bolnikom, pri katerih obstaja večje tveganje za nadaljnje napredovanje okvare ledvic, in pri starejših je treba delovanje ledvic oceniti pogosteje, npr. na 3 do 6 mesecev.
Frequencies of all uncommon adverse reactions were based on the individual mono-components data.
Pogostnosti vseh občasnih neželenih učinkov temeljijo na podatkih o posameznih učinkovinah.
Long-term treatment with metformin has been associated with a decrease in vitamin B12 absorption which may very rarely result in clinically significant vitamin B12 deficiency.
Dolgotrajno zdravljenje z metforminom je bilo povezano z zmanjšanjem absorpcije vitamina B12; to lahko zelo redko povzroči klinično pomembno pomanjkanje vitamina B12.
Qtrilmet is not recommended for children and adolescents under 18 years of age because it has not been studied in these patients.
Uporaba zdravila Qtrilmet ni priporočljiva pri otrocih in mladostnikih, starih manj kot 18 let, ker pri teh bolnikih zdravilo ni raziskano.
Mean absolute lymphocyte counts remained stable with daily dosing up to 102 weeks in duration.
Povprečno absolutno število limfocitov je ostalo stabilno med vsakodnevno uporabo do 102 tedna.
Qtrilmet should not be used during pregnancy.
Zdravila Qtrilmet se med nosečnostjo ne sme uporabljati.
The European Medicines Agency has waived the obligation to submit the results of studies with Qtrilmet in all subsets of the paediatric population in the treatment of type 2 diabetes (see section 4.2 for information on paediatric use).
Evropska agencija za zdravila je odstopila od zahteve za predložitev rezultatov študij z zdravilom Qtrilmet za vse podskupine pediatrične populacije za zdravljenje sladkorne bolezni tipa 2 (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
The majority of events were considered non-serious, mild or moderate in intensity, and resolved.
Večina učinkov ni bila resnih, so bili blagi ali zmerni in so izzveneli.
Interaction studies have been performed with the individual active substances of Qtrilmet.
Študije medsebojnih delovanj so izvedli s posameznimi učinkovinami zdravila Qtrilmet.
Because elderly patients (≥ 65 years) are more likely to have decreased renal function, this medicinal product should be used with caution as age increases.
Ker je pri starejših bolnikih (≥ 65 let) verjetnost za zmanjšano delovanje ledvic večja, je treba to zdravilo z naraščajočo starostjo uporabljati previdno.
This medicine is for a type of diabetes called “type 2 diabetes”.
To zdravilo je namenjeno za zdravljenje vrste sladkorne bolezni, imenovane “sladkorna bolezen tipa 2”.
When driving or using machines, it should be taken into account that dizziness has been reported in studies with saxagliptin.
Pri vožnji ali upravljanju strojev je treba upoštevati, da je bila v študijah s saksagliptinom opisana omotica.
The AUC values of 5-OH-saxagliptin were also increased.
Večja je bila tudi vrednost AUC 5-OH-saksagliptina.
Do not use this medicine after the expiry date, which is stated on the blister and carton after ‘EXP'.
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na pretisnem omotu in škatli poleg oznake ‘EXP'.
p-value < 0.0001. p-value = 0.0166.
Vrednost p = 0,0166.
If no adequate strength of Qtrilmet is available, individual mono-components should be used instead of the modified-release combination.
Če ni na voljo ustrezne jakosti zdravila Qtrilmet, je treba namesto kombinacije s prirejenim sproščanjem uporabiti posamezne sestavine ločeno.
Combinations requiring precautions for use
Kombinacije, ki zahtevajo previdnost
The volume of distribution of saxagliptin was 205 L.
Volumen porazdelitve saksagliptina je 205 l.
Treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses.
Zdravljenje je treba prekiniti pri bolnikih, sprejetih v bolnišnico za večje operacije ali zaradi akutnih resnih internističnih bolezni.
The three medicines in Qtrilmet lower the amount of sugar in the blood by causing it to be taken up into cells or passed out of the body in the urine.
Tri zdravila v zdravilu Qtrilmet zmanjšajo količino sladkorja v krvi; to dosežejo tako, da ali povzročijo njegovo vstopanje v celice ali njegovo izločanje iz telesa z urinom.
The increases in creatinine were generally transient during continuous treatment or reversible after discontinuation of treatment.
Zvišanja kreatinina so bila med nadaljevanjem zdravljenjem na splošno prehodna oziroma po prenehanju zdravljenja reverzibilna.
Due to the limited therapeutic experience with this medicinal product in patients 75 years and older, initiation of therapy is not recommended in this population.
Zaradi omejenih terapevtskih izkušenj s tem zdravilom pri bolnikih, starih 75 let ali več, uvedba zdravljenja pri tej skupini bolnikov ni priporočljiva.
Patients with signs and symptoms of urinary tract infections should be evaluated and promptly treated, if indicated.
Bolnike z znaki in simptomi okužbe sečil je treba ovrednotiti in jih nemudoma zdraviti, če je indicirano.
Patients and/or care-givers should be informed on the risk of lactic acidosis.
Bolnike in/ali njihove skrbnike je treba opozoriti na tveganje laktacidoze.
Organic cation transporters (OCT) Metformin is a substrate of both transporters OCT1 and OCT2.
Prenašalci organskih kationov (OCT - Organic cation transporters) Metformin je substrat prenašalcev OCT1 in OCT2.
Do not stop taking Qtrilmet without talking to your doctor first.
Ne prenehajte jemati zdravila Qtrilmet, ne da bi se prej posvetovali z zdravnikom.
Metformin: The available data in subjects with moderate renal insufficiency are scarce and no reliable estimation of the systemic exposure to metformin in this subgroup as compared to subjects with normal renal function could be made.
Metformin: Podatkov pri osebah z zmerno insuficienco ledvic je malo in tako ni bilo mogoče zanesljivo oceniti sistemske izpostavljenosti metforminu v tej podskupini v primerjavi z osebami z normalnim delovanjem ledvic.
When the patient plans to become pregnant, and during pregnancy, it is recommended that diabetes is not treated with this medicinal product, but insulin be used to maintain blood glucose levels as close to normal as possible, to reduce the risk of malformations of the foetus associated with abnormal blood glucose levels.
Ko bolnica načrtuje nosečnost in med nosečnostjo, je priporočljivo, da se za zdravljenje sladkorne bolezni ne uporablja tega zdravila, temveč insulin, da bi vzdrževali koncentracijo glukoze v krvi čim bližje normalni in tako zmanjšali tveganje za malformacije ploda, povezane z nenormalno koncentracijo glukoze v krvi.
To control your diabetes, you need to follow your doctor's advice on diet and exercise, even when you are taking this medicine.
Za obvladovanje sladkorne bolezni morate upoštevati zdravnikova navodila glede diete in telesne dejavnosti, tudi če jemljete to zdravilo.
Your doctor may prescribe a medicine to treat your allergic reaction and change your diabetes medicine.
Zdravnik vam bo morda predpisal zdravilo za zdravljenje alergijske reakcije in zamenjal zdravilo za sladkorno bolezen.
HbA1c change from baseline at week 24 excluding data after rescue for randomised subjects - studies MB102129 and CV181168
Sprememba HbA1c od izhodišča do 24. tedna, izključujoč podatke pri randomiziranih preiskovancih, pri katerih so uporabili rešilne ukrepe - študiji MB102129 in CV181168
n = number of subjects with non-missing baseline and a week 24 value.
n = število preiskovancev, pri katerih ni bilo manjkajočih vrednosti, ne izhodiščne, ne po 24 tednih.
Use of alternative methods to monitor glycaemic control is advised.
Priporoča se uporaba drugih metod za nadziranje urejenosti glikemije.
Qtrilmet has no or negligible influence on the ability to drive and use machines.
Zdravilo Qtrilmet nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
Onset of symptoms following initiation of therapy may be rapid or may occur after longer periods of treatment.
Simptomi se lahko pojavijo kmalu po začetku zdravljenja ali po daljšem obdobju zdravljenja.
oedema peripheral
periferni edemi
Lactic acidosis Vitamin B12 deficiency
laktacidoza pomanjkan je vitamina B12
Additional safety data include clinical trials, post-authorisation safety studies and post-marketing experience with the mono-components.
Dodatni podatki o varnosti izvirajo iz kliničnih preskušanj, študij varnosti po odobritvi dovoljenja za promet z zdravilom in izkušenj s posameznimi sestavinami v obdobju trženja.
Therapeutic experience in patients 65 years and older is limited, and very limited in patients 75 years and older.
Terapevtskih izkušenj pri bolnikih, starih 65 let ali več, je malo, pri bolnikih, starih 75 let ali več, pa zelo malo.
* LRM = Longitudinal repeated measures using values prior to rescue.
* LPM = longitudinalne ponovljene meritve z uporabo vrednosti pred reševalnim ukrepanjem.
Common A Uncommon B Rare Very rare Not known
Zelo redki Neznana pogostnost
Patients should be advised of the characteristic symptoms of heart failure, and to immediately report such symptoms.
Bolnike je treba seznaniti z značilnimi simptomi srčnega popuščanja in jim naročiti, da morajo o takšnih simptomih takoj poročati.
The safety and efficacy in patients with type 1 diabetes have not been established and Qtrilmet should not be used in patients with type 1 diabetes.
Varnost in učinkovitost pri bolnikih s sladkorno boleznijo tipa 1 nista ugotovljeni in zdravila Qtrilmet se ne sme uporabljati za zdravljenje takšnih bolnikov.
This may occur regardless of blood glucose level.
To se lahko pojavi ne glede na koncentracijo glukoze v krvi.
These may be symptoms of another rare, but very serious, sometimes life-threatening condition called diabetic ketoacidosis.
To so lahko simptomi druge redke, toda zelo resne in včasih smrtno nevarne motnje, imenovane diabetična ketoacidoza.
It is important to check your feet regularly - and follow the advice on foot care from your health care professional.
Pomembno je redno pregledovanje stopal in upoštevanje vseh nasvetov za oskrbo stopal, ki ste jih dobili od zdravstvenega delavca.
This decrease in mean absolute lymphocyte count was not associated with clinically relevant adverse reactions.
To zmanjšanje povprečnega absolutnega števila limfocitov ni bilo povezano s klinično pomembnimi neželenimi učinki.
Due to its mechanism of action, patients taking dapagliflozin will test positive for glucose in their urine.
Zaradi mehanizma delovanja zdravila imajo bolniki, ki jemljejo dapagliflozin, pozitiven izvid testa za glukozo v urinu.
Qtrilmet must be discontinued at the time of surgery with general, spinal or epidural anaesthesia.
Uporabo zdravila Qtrilmet je treba prekiniti v času kirurškega posega v splošni, spinalni ali epiduralni anesteziji.
In particular, talk to your doctor before taking Qtrilmet if you are taking any of the following medicines:
Še zlasti se pred uporabo zdravila Qtrilmet posvetujte z zdravnikom, če jemljete katero od naslednjih zdravil:
If you have type 2 diabetes, your pancreas does not make enough insulin or your body is not able to use the insulin it produces properly.
Če imate sladkorno bolezen tipa 2, v trebušni slinavki ali ne nastaja dovolj insulina ali pa telo ne zmore uporabiti insulina, ki ustrezno nastaja v trebušni slinavki.